HIV
Conditions
Interventions
PLWH with LLV:None
Sponsors
The Public Health Clinical Center of Chengdu
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosised with HIV infection; 2. Over 18 years or above; 3. Taking BIC/FTC/TAF for more than 6 months; 4. HIV-RNA levels was between 50 copies/ml and 200 copies/ml for two consecutive times; 5. Capable of understanding and providing written informed consent; 6. Demonstrates good compliance and is able to cooperate in completing all required examinations and follow-ups during the study period.
Exclusion criteria
Exclusion criteria: 1.Irregular use, discontinuation or cessation of BIC/FTC/TAF 2.Pregnant women, history of organ transplantation, active malignant tumors, opportunistic infection, or other severe complications. 3. Anticipated receipt of immunosuppressive therapy, chemotherapy or continuous steroid therapy during the study period. 4. Patients with unstable mental states or cognitive impairments. 5. Any other conditions deemed unsuitable for study participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete Blood Count ;Blood biochemistry;T-Lymphocyte Count;HIV-RNA Viral Load;plasma concentration of BIC/FTC/TAF; | — |
Countries
China
Contacts
Public ContactDongmei Yan
The Public Health Clinical Center of Chengdu
Outcome results
None listed